ACC Analytic Center

In Press:

Hsu JC, Varosy PD, Bao H, Wang Y, Curtis JP,  Marcus, GM.  2012. Low Body Mass Index but Not Obesity is Associated with In-Hospital Adverse Events and Mortality Among Implantable Cardioverter-Defibrillator Recipients: Insights from the NCDR®. JAHA (in press). 

Farmer SA, Tuohy EJ, Small DS, Wang Y, Groeneveld PW. 2012. The Impact of Community Wealth on Utilization of Cardiac Resynchronization Therapy with Defibrillator for Heart Failure Patients. Circ:CQO (in press).

Published:

Eapen ZJ, Al-Khatib S, Lopes RD, Wang Y, Bao H, Curtis JP, Heidenreich PA, Hernandez AF. 2012. Are Racial/Ethnic Gaps in the Use of Cardiac Resynchronization Therapy Narrowing? An Analysis of 107,096 Patients from the NCDR ICD Registry™. JACC. Published online before print September 5.

Curtis JP, Geary LL, Wang Y, Chen J, Drye EE, Grosso LM, Spertus JA, Rumsfeld JS, Weintraub WS, Masoudi FA, Brindis RG, Krumholz HM. 2012. Development of Two Registry-based Measures Suitable for Characterizing Hospital Performance on 30-day All-Cause Mortality Rates Among Patients Undergoing PCI. Circ Cardiovasc Qual Outcomes. Published online before print September 4.

Cheng A, Wang Y, Berger RD, Calkins H, Buxton AE, Curtis JP, Lampert R. 2012. Electrophysiology Studies in Patients Undergoing ICD Implantation: Findings from the NCDR®. Pacing Clin Electrophysiol. Aug;35(8):912-8.

Dodson JA, Wang Y, Chaudhry SI, Curtis JP. 2012. Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry). Am J Cardiol. Jul 1; 110(1):1-6. (Epub: 2012 Apr 2).

Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis J, Messenger J, Resnic FS, Fitzgerald S. 2012. Bleeding and Vascular Complications at the Femoral Access Site following Percutaneous Coronary Intervention (PCI): An Evaluation of Hemostatis Strategies. J Invasive Cardiol. Jul;24(7):328-34.

Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA. 2012. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Int Med Apr 23; 172(8); 634-641.

Bhatt P, Curtis J, Wang Y, Lampert R. 2012. Impact of the Recent Lead Recall on Utilization of Implantable Cardioverter Defibrillators:  Data from the NCDR ICD Registry™. J Cardiovasc Electrophysiol. Mar 27.

Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. 2012. Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention: Insights from the CATHPCI Registry. Circ Cardiovasc Qual Outcomes. Mar 1;5(2):e16. Epub 2011 Dec 6.

Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. 2012. Optimal medical therapy use among patients receiving implantable cardioverter-defibrillators: Insights from the NCDR®. Arch Intern Med. Jan 9; 172(1);64-7. Epub Nov 14. 

Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. 2012. Physician Procedure Volume and Complications of Cardioverter-Defibrillator Implantation. Circulation. Jan 3;125(1):57-64. Epub 2011 Nov 17.

Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA; National Cardiovascular Data Registry. 2011. Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals. J Am Geriatr Soc. Sep;59(9):1589-95.

Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA; National Cardiovascular Data's ICD Registry. 2011. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. Sep;4(5):549-56.

Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. 2011. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol. Aug 30;58(10):1007-13.

Wei S, Loyo-Berríos NI, Haigney MC, Cheng H, Pinnow EE, Mitchell KR, Beachy JH, Woodward AM, Wang Y, Curtis JP, Marinac-Dabic D. 2011. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation. Circ Cardiovasc Qual Outcomes. May;4(3):346-54. Epub 2011 Apr 12.

Matlock DD, Kutner JS, Emsermann CB, Al-Khatib SM, Sanders GD, Dickinson LM, Rumsfeld JS, Davidson AJ, Crane LA, Masoudi FA. 2011. Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators. J Card Fail. 2011 Apr;17(4):318-24. Epub 2011 Feb 22.

Haines DE, Wang Y, Curtis J. 2011. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation. May 17;123(19):2069-76. Epub 2011 May 2.

Matlock, DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, Curtis JP, Kutner JS,  Fisher ES, and Masoudi FA. 2011. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 4(1): 114-21.

Cheng A, Wang Y, Curtis JP, Varosy PD. 2010. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. J Am Coll Cardiol 56(20): 1651-6.

Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR. 2010. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. J Am Coll Cardiol 56(10): 766-73.

Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. 2010. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 56(14): 1133-9.

Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K,  Blum L, Masoudi F, Rumsfeld J, Brindis RG. 2010. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 7(9): 1340-5.

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. 2009. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 301(16): 1661-70.

Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA. 2009. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Am Heart J 158(2): 224-9.

Farmer SA, Kirkpatrick JN, Heidenreich JA, Curtis JP, Wang Y, Groeneveld PW. 2009. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm 6(3): 325-31.

Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, McKay C, Wang Y, Lang CM, Pontzer K, Rumsfeld J, Phurrough SE, Curtis JP, Brindis RG. 2009. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 6(9): 1397-401.

Peterson PN, Daugherty SL, YWang, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. 2009. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 119(8): 1078-84.

Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, Krumholz HM. 2009. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ 338: b1807.

Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA. 2009. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 6(11): 1565-71.

Chakrabarti A, Krumholz HM, Wang Y, Rumsfeld JS, Nallamothu BK. 2008. Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol 51(25): 2442-3.

Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ,  Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG. 2008. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 5(9): 1359-63.

Nallamothu BK, Wang Y, Bradley EH, Ho KK, Curtis JP, Rumsfeld JS, Masoudi FA, Krumholz HM. 2007. Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry. J Am Coll Cardiol 50(15): 1517-9.

Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich PA, Lindsay BD, Mirro MJ,  Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG. 2007. Review of the registry's first year, data collected, and future plans. Heart Rhythm 4(9): 1260-3.